UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039957
Receipt number R000045557
Scientific Title Multicenter prospective study of risk factors for conversion to laparotomy in patients undergoing laparoscopic liver resection. (HiSCO 08)
Date of disclosure of the study information 2020/03/26
Last modified on 2023/09/13 09:08:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter prospective study of risk factors for conversion to laparotomy in patients undergoing laparoscopic liver resection. (HiSCO 08)

Acronym

Multicenter prospective study of risk factors for conversion to laparotomy in patients undergoing laparoscopic liver resection. (HiSCO 08)

Scientific Title

Multicenter prospective study of risk factors for conversion to laparotomy in patients undergoing laparoscopic liver resection. (HiSCO 08)

Scientific Title:Acronym

Multicenter prospective study of risk factors for conversion to laparotomy in patients undergoing laparoscopic liver resection. (HiSCO 08)

Region

Japan


Condition

Condition

Liver tumor

Classification by specialty

Surgery in general Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the risk factors for conversion to laparotomy in patients undergoing laparoscopic liver resection.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Risk factors for conversion to laparotomy

Key secondary outcomes

Operation time
Bleeding volume


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

liver resection

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Partial liver resection or left lateral segmentectomy for single liver tumor of 5 cm or less in the peripheral liver.
2. ECOG performance status of 0-1.
3. Written informed consent for laparoscopic liver resection.

Key exclusion criteria

1. Clinically significant allergy.
2. Clinically significant heart disease.
3. Clinically significant cirrhosis.
4. Clinically significant respiratory disease.
5. Clinically significant infection.
6. Anatomical liver resection other than left lateral segmentectomy.
7. Resection of other organs other than gallbladder. Gastrointestinal anastomosis. Biliary reconstruction. Lymph node dissection. Revascularization.
8. Patients whom doctors consider unsuitable.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Hideki
Middle name
Last name Ohdan

Organization

Hiroshima University Hospital

Division name

Gasroenterological Surgery

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, JAPAN

TEL

082-257-5222

Email

jimukyoku@hisco-jpn.com


Public contact

Name of contact person

1st name Tsuyoshi
Middle name
Last name Kobayashi

Organization

Hiroshima University Hospital

Division name

Gasroenterological Surgery

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, JAPAN

TEL

082-257-5222

Homepage URL

http://www.hisco-jpn.com/index.html

Email

tsukoba@hiroshima-u.ac.jp


Sponsor or person

Institute

Gasroenterological Surgery, Hiroshima University Hospital

Institute

Department

Personal name



Funding Source

Organization

Hiroshima University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hiroshima University

Address

1-2-3 Kasumi, Minami-ku, Hiroshima, JAPAN

Tel

082-257-5907

Email

iryo-seisaku@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 03 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 03 Month 26 Day

Date of IRB

2020 Year 05 Month 27 Day

Anticipated trial start date

2020 Year 05 Month 28 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 03 Month 26 Day

Last modified on

2023 Year 09 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045557


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name